Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats. - Wikidata - wikimedia - TriplyDB

Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats.

Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats.

http://www.wikidata.org/entity/Q48106802

about

Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective The Yin and Yang of innate immunity in stroke High-mobility group box 1: an amplifier of stem and progenitor cell activity after stroke Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming Evaluation of the Therapeutic Potential of Anti-TLR4-Antibody MTS510 in Experimental Stroke and Significance of Different Routes of Application The role of Toll-like receptors in retinal ischemic diseases Targeting HMGB1 in inflammation Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza A virus (H1N1)-induced pneumonia in mice.Alarmins: awaiting a clinical response Inverse Z-spectrum analysis for spillover-, MT-, and T1 -corrected steady-state pulsed CEST-MRI--application to pH-weighted MRI of acute stroke.Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice.Imaging of amide proton transfer and nuclear Overhauser enhancement in ischemic stroke with corrections for competing effects.Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1 Orally administrated ascorbic acid suppresses neuronal damage and modifies expression of SVCT2 and GLUT1 in the brain of diabetic rats with cerebral ischemia-reperfusion.Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice.Novel HMGB1-inhibiting therapeutic agents for experimental sepsis.Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats.High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.Toll-like receptors and ischemic brain injury.DAMPening inflammation by modulating TLR signalling.Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation.Cynandione A mitigates ischemic injuries in rats with cerebral ischemia.High-mobility group protein box-1 and its relevance to cerebral ischemia Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat model HMGB1 in health and disease.High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling.Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-κB pathway after traumatic brain injury in the rat.Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats Redox regulation of intracellular zinc: molecular signaling in the life and death of neurons Monoclonal anti-HMGB1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models.Toll-like receptors in cerebral ischemic inflammatory injury.Electroacupuncture pretreatment attenuates cerebral ischemic injury through α7 nicotinic acetylcholine receptor-mediated inhibition of high-mobility group box 1 release in rats Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK.HMGB1 contributes to allergen-induced airway remodeling in a murine model of chronic asthma by modulating airway inflammation and activating lung fibroblasts HMGB1 is a therapeutic target for sterile inflammation and infection.Microglial Amyloid-β1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer's Disease.

P2860

Q26774441-01F13E22-80A3-46EB-97FF-966AEC100EDF Q26822268-45810C4D-29D2-4D3D-BBDA-511D4C0EE4F7 Q27008225-876F4F84-76E0-4D91-9374-4224430779A3 Q27013816-640FCBFF-038E-435E-BF7A-CF940EB50C93 Q27323350-9F778319-141C-4727-9E23-AD6BBF67A2D9 Q28072125-297F469B-8CB3-4C28-9D2F-C5DF38041ABF Q28266138-2E6E82B3-8910-4E86-B97D-DB8F74910CD0 Q28384947-A3FD98BA-342B-4F58-9D43-EF18E5C61851 Q30375577-0FB2BF34-8091-4661-A574-5B1EAA59A090 Q30523797-FA6DFA76-2467-4CA7-B76E-EB0AFB9AC5FA Q30726998-8AA782A1-3614-431A-953E-2230E5CE2350 Q30829650-677AAF47-413B-41F1-9B80-C5406DCA86B4 Q30850543-AC2CD07B-413D-42AF-9A46-70B9F7238B99 Q30875468-615E38F0-78B4-4C10-A724-3059C2BF8398 Q31133799-4DEC8177-7411-41C9-A507-B089A16353C5 Q33570445-8CF44A0D-6430-4C93-B8DE-30678F2E9C94 Q33802812-EF4EFF07-3A6E-43EB-B50D-256E4997B5DF Q33814903-15E015C8-EF9C-43E1-96C0-84ABCB782878 Q33814947-55DAA797-4FA3-4BE9-962E-3D928EE0F3AF Q33836853-071779F5-1737-4696-BC69-3D06F3C2E6AB Q33972758-F8EB423B-F8FC-4F20-9D17-01354A2CAF01 Q34035570-64F18A7A-B39A-49F0-AE86-974F6EF53DF5 Q34086987-99A08048-23A4-410A-B37E-297445C1554D Q34151909-4C251474-E0FB-45C9-AA0F-B14FC7EC4B77 Q34170847-16344CC3-320B-4042-A365-538F459FFE51 Q34335584-C30D0114-4F9B-4313-B514-5818A54F5222 Q34622835-E6A6C2D6-C8BD-43DA-B756-966C10F30143 Q34734410-9F025BD0-982D-4476-BBAB-8E04E29347BB Q35070914-65AE536F-ABCA-452B-9197-1BFE8494C152 Q35097291-6E86DB20-A6A4-43D8-B3D0-6965A260A69B Q35104577-1D2935FA-8497-4216-8DD2-CB4AB1571A18 Q35110571-345981DC-46C0-4263-8E23-4AA749B7D860 Q35193898-6A377134-3116-47FA-AAC8-D5896DEC8C7F Q35286874-11EE6C5C-90F0-4578-96D2-01F5819F6190 Q35416110-9EBF873F-70D7-4E0D-A6A0-3F1BB4AF18E3 Q35814948-BD7C5466-23C6-41D6-9738-B681FB8FFCE3 Q35825886-E8A1C80C-70F7-44D5-954F-38F7879E1AC8 Q35833616-F98709AB-675F-4D03-822E-18CDE66D14AE Q35953553-24D89530-804D-485F-8B77-A9E7E479AB0C Q35975429-8C43D0E3-16F1-46B2-9FEB-B5BFAD764DC9

P2860

Anti-high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats.

http://www.wikidata.org/entity/Q48106802

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Anti-high mobility group box 1 ...... by transient ischemia in rats.

@en

Anti-high mobility group box 1 ...... by transient ischemia in rats.

@nl

type

label

Anti-high mobility group box 1 ...... by transient ischemia in rats.

@en

Anti-high mobility group box 1 ...... by transient ischemia in rats.

@nl

prefLabel

Anti-high mobility group box 1 ...... by transient ischemia in rats.

@en

Anti-high mobility group box 1 ...... by transient ischemia in rats.

@nl

P1433

Q48106802-E4D3FBE9-05EA-4CED-A68C-2D2B4F6E14A1

P1476

Q48106802-ACE925A0-C90F-41BA-9F5A-E54BB33007C4

P2093

Q48106802-1B8B75B0-6697-4F28-8B87-D426DD8A5053

Q48106802-708FB3FC-717D-4507-AD28-6F58FDC923CD

Q48106802-7DD0E420-1B65-465D-B88E-B358F78F7DE0

Q48106802-91A04C7D-9B6F-4961-9783-32209C9BDB47

Q48106802-94C8BE0F-1430-46BA-9275-B709A9A21590

Q48106802-BCDAEB12-69C8-41B6-992D-7FD5F5AEFA40

Q48106802-C9BE8189-4D1B-4D3A-BE2C-196FEEDB2ED1

Q48106802-E2897442-4CBD-4B52-A526-61F643513182

Q48106802-F1A03258-0B9B-4192-82D9-2175C8F734A8

Q48106802-FFCBF39F-4C45-4A11-8BB6-1AF662110E03

P304

Q48106802-E2926BFA-46DE-4EFE-B38D-6509BE8CD025

P31

Q48106802-0ED5AFDA-63B6-4802-AD17-19CBEDCDAA3B

P356

Q48106802-F8B524C6-EBE5-4DCC-91AC-BBFE77938422

P407

Q48106802-A2B8BF0E-86AC-4A5F-AE98-B9DDE44469C4

P433

Q48106802-794C9D6B-771B-4229-8917-0138E536AB2B

P478

Q48106802-6883F9DD-6D52-4AC7-9A45-ABD307A26690

P50

Q48106802-CCD3B111-FF74-4155-AF3B-29432BA7C858

P577

Q48106802-6161CA3D-5E0D-43A0-8B95-A14B0D249EFE

P5875

Q48106802-61D2F8AA-DA89-44F0-B0F2-893B0F8DD040

P698

Q48106802-D6E24185-9920-4639-8258-6B63DD820444

P921

Q48106802-7BCB131C-B613-4CE8-99F4-C09AE61F5AA1

P356

P1433

P1476

Anti-high mobility group box 1 ...... by transient ischemia in rats.

@en

P2093

Hidenori Wake

http://www.w3.org/2001/XMLSchema#string

Keyue Liu

http://www.w3.org/2001/XMLSchema#string

Masahiro Nishibori

http://www.w3.org/2001/XMLSchema#string

Naoto Adachi

http://www.w3.org/2001/XMLSchema#string

Norihito Hiraga

http://www.w3.org/2001/XMLSchema#string

Shuji Mori

http://www.w3.org/2001/XMLSchema#string

Tadashi Yoshino

http://www.w3.org/2001/XMLSchema#string

Toru Kanke

http://www.w3.org/2001/XMLSchema#string

Yasuharu Sato

http://www.w3.org/2001/XMLSchema#string

Yasuko Tomono

http://www.w3.org/2001/XMLSchema#string

P304

3904-3916

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.07-8770COM

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Hideo Kohka Takahashi

P577

2007-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6210232

http://www.w3.org/2001/XMLSchema#string

P698

17628015

http://www.w3.org/2001/XMLSchema#string

P921